Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The section 3 NATALEE trial (NCT03701334) investigated the effectiveness and security of including ribociclib (Kisqali) to straightforward hormone remedy for sufferers with hormone...
At no cost actual time breaking information alerts despatched straight to your inbox signal as much as our breaking information emailsSignal as much...
